Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Treatment Persistence and Switching Patterns of Adalimumab Biosimilar ABP 501 in European Patients with Rheumatologic Diseases.
Journal: Rheumatology and therapy
Published: November 02, 2023
Treatment patterns and clinical outcomes in patients with rheumatoid arthritis initiating etanercept, adalimumab, or Janus kinase inhibitor as first-line therapy: results from the real-world CorEvitas RA Registry.
Journal: Arthritis research & therapy
Published: March 30, 2023
Factors Associated With Maintenance of Remission Following Change From Combination Therapy to Monotherapy in Patients With Rheumatoid Arthritis.
Journal: The Journal of rheumatology
Published: February 16, 2023
Occurrence of adverse events and change in disease activity after initiation of etanercept in paediatric patients with juvenile psoriatic arthritis in the CARRA Registry.
Journal: RMD open
Published: December 16, 2022
Effects of Disease-Worsening Following Withdrawal of Etanercept or Methotrexate on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis: Results From the SEAM-RA Trial.
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Published: December 02, 2022
Real-World Evidence Assessing Psoriatic Arthritis by Disease Domain: An Evaluation of the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
Journal: ACR open rheumatology
Published: November 18, 2022
The Economic Benefit of Remission for Patients with Rheumatoid Arthritis.
Journal: Rheumatology and therapy
Published: April 12, 2022
Potential Impact of Sex and BMI on Response to Therapy in Psoriatic Arthritis: Post Hoc Analysis of Results From the SEAM-PsA Trial.
Journal: The Journal of rheumatology
Published: March 25, 2022
Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial.
Journal: RMD open
Published: March 24, 2022
Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid Arthritis.
Journal: Rheumatology and therapy
Published: July 02, 2021
Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry.
Journal: Pediatric rheumatology online journal
Published: May 18, 2021
Treatment patterns in rheumatoid arthritis patients newly initiated on biologic and conventional synthetic disease-modifying antirheumatic drug therapy and enrolled in a North American clinical registry.
Journal: Arthritis research & therapy
Published: March 25, 2021
Last Updated: 09/26/2026